Gault Cheryl
Chief Operating Officer
Gault Cheryl has filed 5 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Jul 1, 2026.
On the most recent filing, Gault Cheryl is listed as Chief Operating Officer at Rapport Therapeutics, Inc. Inside the rolling window, Gault Cheryl reported no open-market purchases and 5 open-market sales totaling $1.1M in RAPP. The largest disclosed transaction in the window is a sale of 10,000 RAPP shares on Jun 30, 2026, worth $416K.
Companies traded
Other insiders at RAPP
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.1M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Gault Cheryl made?
Gault Cheryl has filed 5 SEC Form 4 filings (11 transaction rows) across 1 company since 2025.
Which companies does Gault Cheryl trade?
Gault Cheryl has filed SEC Form 4 disclosures for 1 company, including RAPP.
When was Gault Cheryl's most recent SEC Form 4 filing?
Gault Cheryl's most recent SEC Form 4 filing on Tracefour is dated Jul 1, 2026.
What is Gault Cheryl's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Gault Cheryl is listed as Chief Operating Officer.
What is Gault Cheryl's total buy and sell value in the current window?
Inside the rolling retention window, Gault Cheryl bought $0 and sold $1.1M based on SEC Form 4 filings.
What was Gault Cheryl's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,000 RAPP shares on 2026-06-30, worth $416K, per SEC Form 4 filings.